Sanoptis targets Spain for expansion

Sanoptis, Germany’s second largest ophthalmology group by revenue, is looking to expand in Spain, and beyond, and looking at targets to buy.

Henry Dunant-Euromedica merger unlikely to sell for three years

The company formed as a result of the merger between Euromedica and Imithea, the parent company of Henry Dunant, Greece’s largest private hospital, is unlikely to sell for three years, HBI hears. Click here to read our reports on the for-profit hospital sector, and here to read more about Euromedica, and here to read more […]

Euromedica probe may scupper Henry Dunant deal

The Greek and US governments are investigating vulture fund Farallon's purchase of Euromedica back in 2020. That could scupper Euromedica's planned merger with Imithea – the parent company of Greece’s largest single private hospital Henry Dunant.

HBI 2022: How digitalisation is driving a service revolution

The arguments for digitalisation in healthcare services are well-established, and thanks to the pandemic, hybrid models are coming more and more to the fore. How is digitalisation being used to improve financial outcomes, and how is data being used to deliver unprecedented proactive and preventative measures? 

Affidea deal – underbidders and EBITDA

HBI hears that the surprise buyer of European imaging and cancer treatment provider Affidea, Groupe Bruxelles Lambert (GBL) may not have been the highest bidder, despite winning out. HBI considers who else was in the running, and the EBITDA figure that may have been used for the deal.

Affidea bought by Groupe Bruxelles Lambert

Groupe Bruxelles Lambert (“GBL”) has signed definitive agreements to acquire a majority stake in European imaging and cancer treatment provider Affidea from B-FLEXION, the private investment firm of the Switzerland-based billionaire Bertarelli family. GBL will invest up to €1bn of equity for the transaction which is its first substantive healthcare investment.

Affidea sale – potential price and buyers

European imaging and cancer treatment provider Affidea is for sale according to multiple sources. HBI chats to an operator source to find about more about the sale and to speculate on price and purchasers.

Find Us